NK-1 receptor antagonists anesthesia recovery

Details for Australian Patent Application No. 2005216706 (hide)

Owner Pfizer Products Inc.

Inventors Hickman, Mary Anne; Miskell, Christine Edna

Agent Spruson & Ferguson

Pub. Number AU-B-2005216706

PCT Pub. Number WO2005/082366

Priority 60/540,697 30.01.04 US

Filing date 6 January 2005

Wipo publication date 9 September 2005

Acceptance publication date 29 November 2007

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/082366 Priority application(s): WO2005/082366

29 November 2007 Application Accepted

  Published as AU-B-2005216706

3 April 2008 Standard Patent Sealed

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216707-Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration

2005216703-Treatment of bacterial infections